This is a $2,753,901.72 firm-fixed price purchase order contract awarded by the U.S. Army Medical Command (MEDCOM) to Sysmex America, Inc., a U.S. subsidiary of the Japanese clinical laboratory systems manufacturer Sysmex Corporation. The contract is for hematology testing services to be provided at the Brooke Army Medical Center in Fort Sam Houston, Texas. The contract has a base period of performance from October 1, 2021 to September 30, 2022, with four 12-month option periods through September 30, 2026. The contract was awarded under a competitive, unrestricted solicitation, and is not a small business set-aside. The contract requires the provision of hematology analyzers, reagents, controls, calibration kits, preventative maintenance, and cost-per-test services that must integrate with the Department of Defense's electronic health record systems. Sysmex America has previously received numerous federal contract awards from agencies such as the VA, DoD, and HHS to provide clinical laboratory equipment and services.
Generated 3/13/25, 9:46 AM